Watchful Waiting Urged for Indolent Lymphoma During COVID-19 Watchful Waiting Urged for Indolent Lymphoma During COVID-19

The threshold for treatment initiation during the COVID-19 pandemic should be high for patients with indolent lymphomas, the American Society of Hematology advises.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news